The federal contract award, valued at $31,471.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,052.32 contract is for the procurement of 4,562,235,883 units of the medication Trileptal 300 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $9,385.28 and covers the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB24FC6A5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRILEPTAL 600 MG TABLET 100S, a medication, with a ceiling value of $3,275.96 and a period of performance through July 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the place of performance is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $7,223.90 firm fixed-price delivery order is for the supply of 250 ml bottles of the drug Trileptal, a medication used to treat certain types of seizures. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,705.59 Firm Fixed Price Delivery Order, with a completion date of March 1, 2023, is for the supply of 4560094860 - TRILEPTAL 300 MG/5 ML SUSP 250ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,079.45 firm-fixed-price delivery order is for the supply of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award, identified as SPE2DB20D3505|SPE2DB24FT2X1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product, with a ceiling value of $1,785.44 and a completion date of October 26, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $2,853.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles, with a completion date of May 31, 2023. This contract is not designated as a set-aside and is issued as a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, issued by the Defense Logistics Agency (DLA). The contract, valued at $1,607.25, is a Delivery Order with a Firm Fixed Price pricing type. The award covers the delivery of Trileptal, a 300 mg/5 ml suspension medication, with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...